Product Code: ETC328469 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The human combination vaccines market in the Philippines has witnessed strong government support for immunization programs, contributing to steady growth. The CAGR for this market is expected to be about 1.9%.
The Philippines human combination vaccines market is driven by increasing awareness of the importance of immunization, government initiatives to improve vaccination rates, and advancements in vaccine research and technology. The convenience of receiving multiple vaccines in a single dose also contributes to the market growth.
The Philippines Human Combination Vaccines Market might face challenges in terms of vaccine hesitancy and public awareness about the importance of combination vaccines. Ensuring cold chain logistics for storage and distribution of vaccines in a country with diverse geographic features can also be a challenge. Regulatory approvals and safety concerns are critical aspects of this market.
The human combination vaccines market in the Philippines has faced challenges due to disruptions in healthcare services and reduced access to medical facilities caused by the pandemic. The decline in routine vaccinations and overall healthcare activities has affected the market. The market is expected to recover as healthcare services resume.
In the Philippines Human Combination Vaccines Market, leading companies are GlaxoSmithKline plc, Sanofi Pasteur SA, and Merck & Co., Inc.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Human Combination Vaccines Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Human Combination Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Human Combination Vaccines Market - Industry Life Cycle |
3.4 Philippines Human Combination Vaccines Market - Porter's Five Forces |
3.5 Philippines Human Combination Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Human Combination Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Philippines Human Combination Vaccines Market Revenues & Volume Share, By Combination Type, 2021 & 2031F |
3.8 Philippines Human Combination Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Human Combination Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases. |
4.2.2 Government initiatives and programs promoting vaccination coverage. |
4.2.3 Rising healthcare expenditure and improved access to healthcare services. |
4.3 Market Restraints |
4.3.1 High cost associated with human combination vaccines. |
4.3.2 Limited awareness and education about the benefits of combination vaccines. |
4.3.3 Concerns about vaccine safety and potential side effects. |
5 Philippines Human Combination Vaccines Market Trends |
6 Philippines Human Combination Vaccines Market, By Types |
6.1 Philippines Human Combination Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Human Combination Vaccines Market Revenues & Volume, By Product Type, 2021-2031F |
6.1.3 Philippines Human Combination Vaccines Market Revenues & Volume, By Inactivated Vaccine, 2021-2031F |
6.1.4 Philippines Human Combination Vaccines Market Revenues & Volume, By Live Attenuated Vaccine, 2021-2031F |
6.2 Philippines Human Combination Vaccines Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Philippines Human Combination Vaccines Market Revenues & Volume, By Children, 2021-2031F |
6.2.3 Philippines Human Combination Vaccines Market Revenues & Volume, By Adults, 2021-2031F |
6.3 Philippines Human Combination Vaccines Market, By Combination Type |
6.3.1 Overview and Analysis |
6.3.2 Philippines Human Combination Vaccines Market Revenues & Volume, By Dtap/IPV/HEP B, 2021-2031F |
6.3.3 Philippines Human Combination Vaccines Market Revenues & Volume, By Dtap/HIB/IPV, 2021-2031F |
6.3.4 Philippines Human Combination Vaccines Market Revenues & Volume, By MMR II, 2021-2031F |
6.3.5 Philippines Human Combination Vaccines Market Revenues & Volume, By HEP B-HIB, 2021-2031F |
6.3.6 Philippines Human Combination Vaccines Market Revenues & Volume, By Others, 2021-2031F |
6.4 Philippines Human Combination Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Human Combination Vaccines Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4.3 Philippines Human Combination Vaccines Market Revenues & Volume, By Retailer Pharmacies, 2021-2031F |
6.4.4 Philippines Human Combination Vaccines Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Philippines Human Combination Vaccines Market Import-Export Trade Statistics |
7.1 Philippines Human Combination Vaccines Market Export to Major Countries |
7.2 Philippines Human Combination Vaccines Market Imports from Major Countries |
8 Philippines Human Combination Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates among different age groups. |
8.2 Number of public health campaigns promoting vaccination. |
8.3 Percentage of healthcare professionals recommending human combination vaccines. |
8.4 Research and development investment in improving vaccine efficacy and safety. |
8.5 Number of reported vaccine-preventable disease cases. |
9 Philippines Human Combination Vaccines Market - Opportunity Assessment |
9.1 Philippines Human Combination Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Human Combination Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Philippines Human Combination Vaccines Market Opportunity Assessment, By Combination Type, 2021 & 2031F |
9.4 Philippines Human Combination Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Human Combination Vaccines Market - Competitive Landscape |
10.1 Philippines Human Combination Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Philippines Human Combination Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |